131 related articles for article (PubMed ID: 35086068)
1. BAIRDA: a novel
Chow B; Warkentin B; Nanda K; Ghosh S; Huang F; Gamper AM; Menon G
Phys Med Biol; 2022 Feb; 67(4):. PubMed ID: 35086068
[No Abstract] [Full Text] [Related]
2. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
Pop LA; Millar WT; Visser AG; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
[TBL] [Abstract][Full Text] [Related]
4. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments.
Visser AG; van den Aardweg GJ; Levendag PC
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):497-505. PubMed ID: 8567354
[TBL] [Abstract][Full Text] [Related]
5. Uncertainties Associated with Clonogenic Assays using a Cs-137 Irradiator and Ir-192 Afterloader: A Comprehensive Compilation for Radiation Researchers.
Chow B; Warkentin B; McEwen M; Huang F; Nanda K; Gamper AM; Menon G
Radiat Res; 2022 Jul; 198(1):40-56. PubMed ID: 35391488
[TBL] [Abstract][Full Text] [Related]
6. Radiobiological dose calculation parameters for cervix cancer brachytherapy: A systematic review.
Chow B; Warkentin B; Menon G
Brachytherapy; 2019; 18(4):546-558. PubMed ID: 30956052
[TBL] [Abstract][Full Text] [Related]
7. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
8. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
King CR
Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170
[TBL] [Abstract][Full Text] [Related]
9. Radiobiological comparison between Cobalt-60 and Iridium-192 high-dose-rate brachytherapy sources: Part I-cervical cancer.
Dayyani M; Hoseinian-Azghadi E; Miri-Hakimabad H; Rafat-Motavalli L; Abdollahi S; Mohammadi N
Med Phys; 2021 Oct; 48(10):6213-6225. PubMed ID: 34415623
[TBL] [Abstract][Full Text] [Related]
10. The effect of alternative biological modelling parameters (α/β and half time of repair T ½ ) on reported EQD2 values in the treatment of advanced cervical cancer.
De Leeuw AA; Van de Kamer JB; Moerland MA; Philippens ME; Jürgenliemk-Schulz IM
Radiother Oncol; 2011 Nov; 101(2):337-42. PubMed ID: 21742393
[TBL] [Abstract][Full Text] [Related]
11. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.
le Guyader M; Lam Cham Kee D; Thamphya B; Schiappa R; Gautier M; Chand-Fouche ME; Hannoun-Levi JM
Clin Transl Radiat Oncol; 2022 Jan; 32():15-23. PubMed ID: 34816022
[TBL] [Abstract][Full Text] [Related]
13. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
[TBL] [Abstract][Full Text] [Related]
14. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
[TBL] [Abstract][Full Text] [Related]
15. The equivalent dose contribution from high-dose-rate brachytherapy to positive pelvic lymph nodes in locally advanced cervical cancer.
Lee YC; Rash DL; Stern RL; Mayadev JS
Brachytherapy; 2013; 12(6):555-9. PubMed ID: 23880417
[TBL] [Abstract][Full Text] [Related]
16. A simple method of obtaining equivalent doses for use in HDR brachytherapy.
Nag S; Gupta N
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):507-13. PubMed ID: 10661360
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer.
Sun B; Yang D; Esthappan J; Garcia-Ramirez J; Price S; Mutic S; Schwarz JK; Grigsby PW; Tanderup K
Brachytherapy; 2015; 14(4):481-9. PubMed ID: 25958039
[TBL] [Abstract][Full Text] [Related]
18. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
19. Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.
Liu WS; Yen SH; Chang CH; Yang KM; Wu YP; Chen KY
Gynecol Oncol; 1996 Feb; 60(2):295-300. PubMed ID: 8631555
[TBL] [Abstract][Full Text] [Related]
20. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]